Triazine dimers for the treatment of autoimmune diseases

Details for Australian Patent Application No. 2004291186 (hide)

Owner Prometic Biosciences Inc.

Inventors Cameron, Alan D.; Grouix, Brigitte; Fortin, Daniel; Duceppe, Jean-Simon; Penney, Christopher; Wilb, Nicole; Ezzitouni, Abdallah; Zacharie, Boulos; Moreau, Nancie; Bienvenu, JeanFrancois; Abbott, Shaun D.; Gagnon, Lyne; Houde, Karine

Agent Shelston IP

Pub. Number AU-B-2004291186

PCT Pub. Number WO2005/049607

Priority 60/524,021 24.11.03 US

Filing date 22 November 2004

Wipo publication date 2 June 2005

Acceptance publication date 19 January 2012

International Classifications

C07D 251/70 (2006.01) Heterocyclic compounds containing 1,3,5-triazine rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/049607 Priority application(s): WO2005/049607

19 January 2012 Application Accepted

  Published as AU-B-2004291186

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291187-Pipe molding system with vacuum and temperature controls of cooling plugs

2004291184-Cycloalkyl derivatives of 3-hydroxy-4-pyridinones